Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 9—September 2024
Research

Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015–2019

Shihwan Chang1, Sol Kim1, Young Ae Kang, Moo Suk Park, Hojoon Sohn2, and Youngmok Park2Comments to Author 
Author affiliations: Yonsei University College of Medicine, Seoul, South Korea (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Severance Hospital, Seoul (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Seoul National University College of Medicine, Seoul (H. Sohn); Seoul National University Institute of Health Policy and Management, Seoul (H. Sohn)

Main Article

Table 6

Multiple linear regression analysis of factors driving cumulative cost in study of medical costs of nontuberculous mycobacterial pulmonary disease, South Korea, 2015–2019*

Model no., variable(s) B SE β t p value R2 Adjusted R2
1
No. admissions
 6058.547
 627.484
 0.785
 9.655
 <0.001
 0.616
 0.610
2
No. admissions 5503.292 532.913 0.713 10.327 <0.001 0.739 0.730
Causative species: MAC = 0, M. abscessus = 1
 7921.642
 1530.022
 0.358
 5.177
 <0.001
 NA
 NA
3
No. admissions 5379.334 520.642 0.697 10.332 <0.001 0.758 0.746
Causative species: MAC = 0, M. abscessus = 1 7445.211 1502.260 0.336 4.956 <0.001 NA NA
Culture conversion −3082.792 1455.967 −0.142 −2.117 0.039 NA NA

*N = 147 patients. Variables include age, sex, history of tuberculosis, history of nontuberculous mycobacteria treatment, bronchiectasis, asthma, chronic obstructive pulmonary disease, lung cancer, causative species (MAC vs. M. abscessus), total follow-up duration, treatment duration, number of outpatient visits, number of admissions, culture conversion, microbiologic cure, retreatment for recurrence, and death from any cause. MAC, Mycobacterium avium complex; NA, not applicable.

Main Article

1These first authors contributed equally to this article.

2These authors were co–principal investigators.

Page created: July 30, 2024
Page updated: August 13, 2024
Page reviewed: August 13, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external